Optimizing the selection of Parkinson's disease patients for neuromodulation using the levodopa challenge test.

Dinkar KulshreshthaMarcus PietermanGreydon GilmoreMandar S Jog

Published in: Journal of neurology (2021)

Performing a regular levodopa challenge test, when levodopa dose increases substantially, should be considered to determine the ideal time for DBS in patients with Parkinson's disease.

Keyphrases

deep brain stimulation
parkinson disease
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors